Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 295, Issue 1, pp 41–44 | Cite as

Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine

  • Else Müller-Schweinitzer
Article

Summary

Changes in tension of spiral strips from dog saphenous arteries were monitored isometrically. Dose-response curves for noradrenaline, 5-HT and ergotamine were established without and after a 30 min incubation with phentolamine or pizotifen. Phentolamine was about 15 times more potent in antagonizing responses to noradrenaline (pA2 value=7.4) than those to 5-HT (pA2 value=6.2) but it was nearly equipotent in antagonizing responses to ergotamine (pA2 value=6.5) and those to 5-HT. Pizotifen was about 500 times less potent in antagonizing noradrenaline effects than 5-HT but again nearly equipotent when tested against ergotamine and 5-HT.

It is suggested that in canine saphenous arteries the stimulant activity of ergotamine is mediated mainly through 5-HT receptors.

Key words

Arteries Ergotamine 5-HT Receptors Pizotifen Phentolamine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arunlakshana, O., Schild, H. O.: Some quantitative uses of drug antagonists. Brit. J. Pharmacol. 14, 48–58 (1959)Google Scholar
  2. Müller-Schweinitzer, E.: Further studies on the mode of action of ergotamine on canine vein strips. Naunyn-Schmiedeberg's Arch. Pharmacol. 282, Suppl., R 68 (1974)Google Scholar
  3. Müller-Schweinitzer, E.: Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 113–118 (1976)Google Scholar
  4. Müller-Schweinitzer, E., Brundell, J.: Enhanced prostaglandin synthesis contributes to the venoconstrictor activity of ergotamine. Blood Vessels 12, 193–205 (1975)Google Scholar
  5. Müller-Schweinitzer, E., Stürmer, E.: Investigations on the mode of action of ergotamine in the isolated femoral vein of the dog. Brit. J. Pharmacol. 51, 441–446 (1974a)Google Scholar
  6. Müller-Schweinitzer, E., Stürmer, E.: Studies on the mechanism of the venoconstrictor activity of ergotamine on isolated canine saphenous veins. Blood Vessels 11, 183–190 (1974b)Google Scholar
  7. Müller-Schweinitzer, E., Stürmer, E.: Effects of ergotamine on the responses of isolated saphenous and external carotid arteries of the dog to noradrenaline and serotonin. Sixth Internat. Congr. Pharmacol., Helsinki 1975, Abstr. 1555Google Scholar
  8. Schild, H. O.: pA, a new scale for the measurement of drug antagonism. Brit. J. Pharmacol. 2, 189–206 (1947)Google Scholar
  9. Schild, H. O.: Parallelism of log dose-response curves in competitive antagonism. Pharmacol. Res. Commun. 1, 1–2 (1969)Google Scholar
  10. Van Rossum, J. M.: Cumulative dose-response curves (II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters). Arch. int. Pharmacodyn. 143, 299–330 (1963)Google Scholar

Copyright information

© Springer-Verlag 1976

Authors and Affiliations

  • Else Müller-Schweinitzer
    • 1
  1. 1.Medizinisch-Biologische ForschungSandoz AGBaselSwitzerland

Personalised recommendations